Logo

Beyond Genomics and Novartis in Deal on Cardiovascular Research

Feb 12, 2003

Beyond Genomics of Waltham, Mass., and Novartis have announced a collaboration on cardiovascular disease research.

 

Novartis will provide patient plasma samples to Beyond Genomics, which will seek molecular markers for cardiovascular disease through bioinformatics analyses, Beyond Genomics said in a statement.

 

Financial terms were not disclosed.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.